Koalaa develops fabric-based, breathable soft prosthetic sleeves and the world’s first 'early rehab' prosthetic arm that can be used just hours after surgery. Its prosthetics are lightweight, comfortable, suitable for very young children, and feature interchangeable tools driven by user feedback. The company links new users with limb buddies and distributes via clinicians, NGOs and direct-to-consumer channels. Koalaa was founded in 2020, employs a team of 18 people, and has around 1,000 users worldwide. The team plans to continue increasing global access, expand work with clinicians and NGOs, and increase supply of prosthetics to those within conflict zones. New funding will support ongoing product development and growth of the team in the UK and overseas and advance efforts to make products available through the NHS. Koalaa, founded in 2020 and based in west London, develops soft, lightweight prosthetic arms and sleeves designed for babies, children and adults. Its sleeves are made from soft, lightweight materials and are flexible compared with heavy, rigid traditional prosthetics; they can be fitted with interchangeable tool attachments for tasks such as holding a pen, cutting, riding a bike, or playing instruments, and can be used by children as young as one year old. Koalaa operates a 'virtual clinic' model that allows remote measuring, fitting and supply, and provides wearers with community support including a 'limb buddy'. The company secured €145K from British Design Fund under the EIS scheme as its first institutional investment following an angel round in May 2020. The funds will be used to increase manufacturing capacity at its west London facility to meet rising demand, and Koalaa plans to commercialise early rehabilitation soft prosthetic sleeves to aid recovery immediately after amputation. Koalaa also intends to begin launching products and services in select countries across Asia, the Middle East, Africa and North America.

Total raised

$1M

Funding rounds

2

Latest round

Equity

Latest activity

Feb 2024